Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.67 |
| ▸ | LMNA | P02545 | 4/20 | 0.67 |
| ▸ | MEN1 | O00255 | 4/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.67 |
| ▸ | GMNN | O75496 | 3/20 | 0.67 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.67 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.67 |
| ▸ | BLM | P54132 | 2/20 | 0.67 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.67 |
| ▸ | GLA | P06280 | 1/20 | 0.67 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.66 |
| ▸ | TP53 | P04637 | 3/20 | 0.64 |
| ▸ | TSHR | P16473 | 3/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10626781 | 0.94 | MAPK1 (0.72) | MAPTMAPK1LMNAMEN1KMT2A | |
| SCHEMBL2517754 | 0.87 | CYP1A2 (0.69) | MAPTMAPK1LMNAMEN1KMT2A | |
| SCHEMBL22116167 | 0.85 | CYP1A2 (0.82) | MAPTMAPK1LMNAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL8623579 | 0.84 | MAPT (0.68) | MAPTMAPK1LMNAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL9172277 | 0.84 | MAPT (0.67) | MAPTMAPK1LMNAMEN1KMT2A | |
| SCHEMBL22057079 | 0.84 | CYP1A2 (0.66) | MAPTMAPK1LMNAMEN1KMT2A | |
| Butyryl-Carnitine SCHEMBL12137158 | 0.83 | CYP1A2 (0.79) | MAPTMAPK1LMNAMEN1KMT2A | |
| SCHEMBL26640789 | 0.83 | CYP1A2 (0.69) | MAPTMAPK1LMNAMEN1KMT2A | |
| Butyryl-Carnitine SCHEMBL12283483 | 0.83 | CYP1A2 (0.79) | MAPTMAPK1LMNAMEN1KMT2A | |
| SCHEMBL26640719 | 0.83 | LMNA (0.66) | MAPTMAPK1LMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4859698-A | CARDIOVASCULAR DISORDERS, HYPERLIPIDAEMIAS, HYPERLIPOPROTEINAEMIAS/ | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1989-08-22 | — | — | US | disclosed |
| US-4766222-A | CARDIOVASCULAR DISORDERS, ANTIARRHYTHMIA, ANTICHOLESTEROL OR HYPERLIPEMIA AGENTS | SIGMA-TAU INDUSTRIE FARMACUETICHE RIUNITE S.P.A. (IT) | 1988-08-23 | — | — | US | disclosed |